Sonendo (SONX) Price & Analysis

Compare

70 Followers

SONX Stock Chart & Stats

$0.20

$0.19(9.22%)

At close: Jan 07 4:00 PM EST

$0.20

$0.19(9.22%)

Day’s Range― - ―

52-Week Range$0.00 - $2.07

Previous CloseN/A

Volume1.59K

Average Volume (3M)389.00

Market Cap

$72.66K

Enterprise Value$8.80M

Total Cash (Recent Filing)$11.63M

Total Debt (Recent Filing)$18.93M

Price to Earnings (P/E)―

Beta-0.10

Next Earnings

Mar 25, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding427,401

10 Day Avg. Volume222

30 Day Avg. Volume389

Financial Highlights & Ratios

PEG Ratio0.33

Price to Book (P/B)16.56

Price to Sales (P/S)2.71

P/FCF Ratio-3.46

Enterprise Value/Market Cap121.06

Enterprise Value/Revenue0.28

Enterprise Value/Gross Profit0.74

Enterprise Value/Ebitda-0.32

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)-46.56

Revenue Forecast (FY)$42.30M

Bulls Say, Bears Say

Bulls Say

Recurring Revenue ModelSonendo's business centers on capital sales of the GentleWave System plus single-use consumables tied to each procedure. This creates a durable, annuity-like revenue stream once systems are installed, supporting predictable follow-on revenue and higher customer lifetime value over months.

Improving Cash BurnThe company has materially reduced free cash flow losses and cut capital expenditures, which lengthens runway and reduces near-term financing needs. Sustained cash-burn improvement increases strategic flexibility to invest in adoption or commercialization over the next several months.

Early Margin ImprovementA modest uptick in gross profit suggests improving unit economics or cost control on procedures and consumables. If sustained, this enhances long-term margin expansion potential as installed base and utilization grow, supporting pathway to operational breakeven over time.

Bears Say

High Leverage / Weak EquityA leveraged balance sheet with low shareholders' equity raises solvency and refinancing risk. Elevated debt obligations limit capital allocation for sales, training, or R&D, increase interest burden, and reduce resilience to demand variability over the medium term.

Declining Revenue And LossesFalling revenue and sustained net losses undermine the ability to scale consumable-driven recurring revenue. Continued top-line contraction weakens pricing power and installed-base growth, making it harder to achieve operating leverage and durable profitability within several months.

Negative Operating Cash FlowOngoing negative operating cash flow signals the core business does not yet generate sufficient cash to fund operations. This creates dependence on external financing, constrains investment in commercialization initiatives, and poses a persistent risk to sustaining growth and installations.

Sonendo News

Sonendo names John McGaugh COO

Sonendo (SONX) announced the promotion of John McGaugh to Chief Operating Officer. McGaugh previously held the position of...

7M ago

SONX

Sonendo Inc. Reports Improved Margins and Reduced Losses

Sonendo Inc ( ($SONX) ) has released its Q4 earnings. Here is a breakdown of the information Sonendo...

11M ago

SONX

Sonendo Inc (SONX) Q3 Earnings Cheat Sheet

Sonendo Inc (SONX) is scheduled to report 3rd quarter earnings on 11/12/2024, after the market closes. Regarding Q3...

1y ago

SONX

Sonendo executes $14M plus APA to acquire Biolase assets

Sonendo announced that the company has entered into an Asset Purchase Agreement or APA with Biolase and certain...

1y ago

SONX

Sonendo Expands Portfolio and Pursues Damages Against Biolase

The latest update is out from Sonendo ( ($SONX) ). Sonendo, Inc. has agreed to acquire dental laser...

1y ago

SONX

Sonendo Chief Talent Officer Resigns, HR Restructured

Sonendo (SONX) just unveiled an announcement. Roy T. Chen has resigned from his position as Chief Talent Officer...

2y ago

SONX

Sonendo Appoints John Bostjancic as CFO, Expands Talent Inducements

Sonendo (SONX) has shared an update. Sonendo, Inc. has appointed John Bostjancic as its new Chief Financial Officer,...

2y ago

SONX

Sonendo Board Member Sadie Stern Announces Departure

Sonendo (SONX) has issued an announcement. Ms. Sadie Stern has announced she won’t seek reelection to the Board...

2y ago

SONX

Sonendo Inc. on the Brink: NYSE Suspension and Delisting Risks Shake Investor Confidence

Sonendo Inc (SONX) has disclosed a new risk, in the Share Price & Shareholder Rights category. Sonendo Inc....

2y ago

SONX

Sonendo downgraded to Hold from Buy at Stifel

Stifel analyst Jonathan Block downgraded Sonendo to Hold from Buy with a price target of 25c, down from...

2y ago

SONX

SONX Upcoming Earnings Report: What to Expect?

Sonendo Inc (SONX) is scheduled to report 4th quarter earnings on 03/11/2024, after the market closes. Regarding Q4...

2y ago

SONX

Sonendo Announces CFO Resignation and Interim Successor

An update from Sonendo (SONX) is now available. Michael P. Watts has resigned from his role as Chief...

2y ago

SONX

Sonendo Streamlines Operations with Strategic Asset Sale and Credit Revision

Sonendo (SONX) has provided an announcement. TDO Software, Inc., a subsidiary of Sonendo, Inc., has sold its endodontic...

2y ago

SONX

OTC Markets Group welcomes Sonendo to OTCQX

OTC Markets Group announced Sonendo has qualified to trade on the OTCQX Best Market. Sonendo, Inc. previously traded...

2y ago

SONX

SONX FAQ

What was Sonendo’s price range in the past 12 months?

Sonendo lowest stock price was $0.00 and its highest was $2.07 in the past 12 months.

What is Sonendo’s market cap?

Sonendo’s market cap is $72.66K.

When is Sonendo’s upcoming earnings report date?

Sonendo’s upcoming earnings report date is Mar 25, 2026 which is in 22 days.

How were Sonendo’s earnings last quarter?

Currently, no data Available

Is Sonendo overvalued?

According to Wall Street analysts Sonendo’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Sonendo pay dividends?

Sonendo does not currently pay dividends.

What is Sonendo’s EPS estimate?

Sonendo’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Sonendo have?

Sonendo has 427,401 shares outstanding.

What happened to Sonendo’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Sonendo?

Currently, no hedge funds are holding shares in SONX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Sonendo

Sonendo, Inc. (SONX) is a medical technology company specializing in the development of advanced dental technologies, specifically focused on endodontics, or root canal treatments. The company's flagship product, the GentleWave System, utilizes a proprietary ultrasound technology to improve the efficiency and effectiveness of root canal procedures. By enhancing the cleaning and disinfection of the root canal system, Sonendo aims to provide better outcomes for patients while transforming dental practices with innovative solutions.